{"id":"https://openalex.org/W2005805731","doi":"https://doi.org/10.1139/y90-013","title":"Dose-dependent inhibition of cyclosporine metabolism in mice by fluconazole","display_name":"Dose-dependent inhibition of cyclosporine metabolism in mice by fluconazole","alternate_titles":[],"publication_year":1990,"publication_date":"1990-01-01","ids":{"openalex":"https://openalex.org/W2005805731","doi":"https://doi.org/10.1139/y90-013","mag":"2005805731","pmid":"https://pubmed.ncbi.nlm.nih.gov/2328446"},"language":"en","primary_location":{"id":"doi:10.1139/y90-013","doi":"https://doi.org/10.1139/y90-013","is_oa":false,"landing_page_url":"https://doi.org/10.1139/y90-013","pdf_url":null,"source":{"id":"https://openalex.org/S82722058","display_name":"Canadian Journal of Physiology and Pharmacology","issn_l":"0008-4212","issn":["0008-4212","1205-7541"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310312929","host_organization_name":"Canadian Science Publishing","host_organization_lineage":["https://openalex.org/P4310312929"],"host_organization_lineage_names":["Canadian Science Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Physiology and Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005805731"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016618048","display_name":"Ignazio La Delfa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ignazio La Delfa","raw_affiliation_strings":["Department of Medicine, Stanford University Medical Center, CA 94305-5113"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Stanford University Medical Center, CA 94305-5113","institution_ids":["https://openalex.org/I4210137306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057200806","display_name":"Yifan Xia","orcid":"https://orcid.org/0000-0002-2056-364X","observed_orcids":["https://orcid.org/0000-0002-2056-364X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yifan Xia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5088392350","display_name":"Terrence F. Blaschke","orcid":"https://orcid.org/0000-0001-5307-2620","observed_orcids":["https://orcid.org/0000-0001-5307-2620"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Terrence F. Blaschke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2532,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.74238362,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"68","issue":"1","first_page":"89","last_page":"93"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluconazole","display_name":"fluconazole","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9760000109672546},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8479999899864197},{"id":"https://openalex.org/keywords/cytochrome-p450-inhibition","display_name":"cytochrome P450 inhibition","score":0.9819999933242798},{"id":"https://openalex.org/keywords/dose-dependent-inhibition","display_name":"dose-dependent inhibition","score":0.6919999718666077},{"id":"https://openalex.org/keywords/elimination-rate-constant","display_name":"elimination rate constant","score":0.6769999861717224},{"id":"https://openalex.org/keywords/terminal-half-life","display_name":"terminal half-life","score":0.9620000123977661},{"id":"https://openalex.org/keywords/antifungal-agents","display_name":"antifungal agents","score":0.7910000085830688},{"id":"https://openalex.org/keywords/fungal-infection","display_name":"fungal infection","score":0.4819999933242798}],"concepts":[{"id":"https://openalex.org/C2780651595","wikidata":"https://www.wikidata.org/wiki/Q411478","display_name":"Fluconazole","level":3,"score":0.9530220031738281},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.8190773725509644},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6929054260253906},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.5918086767196655},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.5661801695823669},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.5516676306724548},{"id":"https://openalex.org/C89311334","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Drug metabolism","level":3,"score":0.5031248927116394},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4770071804523468},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.46455973386764526},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4491519629955292},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4032113552093506},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3476340174674988},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22929295897483826},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.16184169054031372},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.08998551964759827},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000983","descriptor_name":"Antipyrine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003524","descriptor_name":"Cyclosporins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015725","descriptor_name":"Fluconazole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1139/y90-013","doi":"https://doi.org/10.1139/y90-013","is_oa":false,"landing_page_url":"https://doi.org/10.1139/y90-013","pdf_url":null,"source":{"id":"https://openalex.org/S82722058","display_name":"Canadian Journal of Physiology and Pharmacology","issn_l":"0008-4212","issn":["0008-4212","1205-7541"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310312929","host_organization_name":"Canadian Science Publishing","host_organization_lineage":["https://openalex.org/P4310312929"],"host_organization_lineage_names":["Canadian Science Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Physiology and Pharmacology","raw_type":"journal-article"},{"id":"pmid:2328446","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2328446","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian journal of physiology and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4539214273","display_name":"KINETICS OF DRUG-DRUG AND DRUG-DISEASE INTERACTIONS","funder_award_id":"R01GM022209","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W143103854","https://openalex.org/W1974535674","https://openalex.org/W2002480085","https://openalex.org/W2010915507","https://openalex.org/W2011432259","https://openalex.org/W2015994420","https://openalex.org/W2016784435","https://openalex.org/W2018535826","https://openalex.org/W2033420061","https://openalex.org/W2035268683","https://openalex.org/W2035535554","https://openalex.org/W2080721443","https://openalex.org/W2088376335","https://openalex.org/W2167867126","https://openalex.org/W2224187832","https://openalex.org/W3122881710"],"related_works":["https://openalex.org/W1597211147","https://openalex.org/W2127288395","https://openalex.org/W2224187832","https://openalex.org/W1795392936","https://openalex.org/W2329139209","https://openalex.org/W1985250768","https://openalex.org/W4252227462","https://openalex.org/W2142121004","https://openalex.org/W2049104085","https://openalex.org/W2115067071"],"abstract_inverted_index":{"Fluconazole,":[0],"a":[1,13,101,148],"potent":[2,149],"bis-triazole":[3],"antimycotic":[4],"drug,":[5],"has":[6],"been":[7],"demonstrated":[8],"to":[9,169],"inhibit":[10],"antipyrine":[11],"metabolism,":[12],"cytochrome":[14,27,153],"P-450":[15,28,154],"dependent":[16,155],"process,":[17],"in":[18,20,31,48,50,70,75,83,90,125,132,142,158,163],"vivo":[19,49,143],"mice.":[21,51,159],"Cyclosporine":[22],"is":[23,147],"metabolized":[24],"by":[25,118],"the":[26,44,66,84,91,105,109,116,126,152],"enzyme":[29,156],"system":[30,157],"both":[32],"mice":[33,72],"and":[34,62,88,108,111,120,165],"man.":[35],"We":[36],"investigated":[37],"whether":[38],"fluconazole":[39,59,146],"had":[40],"any":[41],"effects":[42,53],"on":[43,65],"metabolism":[45,67],"of":[46,54,58,68,94,104,135,151],"cyclosporine":[47,69],"The":[52,96],"three":[55],"different":[56],"doses":[57,124],"(1,":[60],"5,":[61],"20":[63,112],"mg/kg)":[64],"CD-1":[71],"were":[73],"studied":[74],"single-dose":[76],"experiments.":[77],"Fluconazole":[78,123],"produced":[79],"significant":[80],"dose-dependent":[81],"decreases":[82],"elimination":[85],"rate":[86],"constant":[87],"increases":[89],"terminal":[92,106],"half-life":[93,107,117],"cyclosporine.":[95],"1":[97],"mg/kg":[98,113,128],"dose":[99,114],"caused":[100],"26%":[102],"prolongation":[103],"5":[110],"prolonged":[115],"72":[119],"187%,":[121],"respectively.":[122],"1-5":[127],"range":[129],"are":[130,167],"effective":[131],"mouse":[133],"models":[134],"fungal":[136],"infections.":[137],"These":[138],"results":[139],"provide":[140],"further":[141],"evidence":[144],"that":[145],"inhibitor":[150],"Future":[160],"experimental":[161],"studies":[162],"animals":[164],"humans":[166],"needed":[168],"evaluate":[170],"possible":[171],"metabolic":[172],"drug-drug":[173],"interactions":[174],"involving":[175],"fluconazole.":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005805731","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}
